The scenario FormBlends considers most likely: full cessation by Q1 2027, followed by a 12-18 month period of tight brand-name supply and high out-of-pocket costs, then gradual relief as generic oral semaglutide enters the market in late 2027 and generic injectable semaglutide enters in 2031-2032
Long-term effects on people have not been established, and the trials are still running
Given the immense popularity of these drugs, regulators and the medical establishment need urgently to figure out how to best capture and keep pace with the experiment
Howard tells his own patients to look for symptoms that dont overlap with typical Ozempic side effects, such as dark or decreased urine, dizziness when you stand up, a racing heart, and nausea that prevents you from keeping fluids down
Body mass index does not take into account the amount of LBM or lean body mass (muscle tissue) that a person has, just overall body weight